Daily Digest: Last 2 Hours: Stroke Risk, Industry Maturation, and Reassurance for Older Adults — March 09, 2026
A synthesis of 9 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Daily Digest: Cannabis and Stroke Risk in Focus as Texas Expands Access — March 09, 2026
This digest highlights cannabis and stroke risk with new research emphasizing cardiovascular concerns. Texas expands medical cannabis access, reflecting growing infrastructure. Edible cannabis pharmacokinetics also receive attention in this update.
Daily Digest: Last 9 Hours: Stroke Risk From Recreational Drugs and DEA Scheduling Actions — March 08, 2026
A synthesis of 12 recently added cannabis articles — key themes, clinical context, and Dr. Caplan's take.
Daily Digest: Last 38 Hours: Cannabinoids, Liver Disease, and the Adolescent Brain — March 08, 2026
This digest highlights cannabinoid drug delivery breakthroughs alongside key findings on liver disease and adolescent brain health. Advances in delivery technology improve cannabinoid bioavailability and therapeutic potential. Clinicians should consider…
Daily Digest: Last 24 Hours: Cannabinoids and Liver Disease Lead a Research-Heavy Cycle — March 08, 2026
This digest highlights the latest research on cbd and cbg for fatty liver disease, emphasizing key clinical implications. Advances in cannabinoid drug delivery science also feature prominently. Regulatory updates across North America further shape the…
Daily Digest: Cannabinoids and Liver Disease Lead a Busy News Cycle — March 07, 2026
This cycle highlights cognitive safety in older adults cannabis use as a key research focus. Emerging clinical evidence complements findings on cannabinoids and fatty liver disease. State-level cannabis policy developments also impact patient access and…
Daily Digest: Last 7 Hours: Cannabis, Liver Disease, and the Policy Gaps That Still Haunt Patients — March 07, 2026
This digest highlights policy regulation cannabis patient access challenges that persist despite legalization. Patients face barriers due to regulatory gaps that limit real access. Understanding these issues is crucial for clinicians and patients alike.
Daily Digest: Cannabinoids and Fatty Liver Disease Promise Amid Regulatory Gaps — March 06, 2026
This digest reviews cannabinoids and liver disease research with a focus on emerging preclinical evidence for fatty liver disease. The research highlights promising mechanisms but also regulatory gaps. Clinicians remain cautious pending robust clinical…
Daily Digest: Last 6 Hours: Cognitive Safety, Liver Disease Breakthroughs, and the Drug Testing Problem That Won’t Go Away — March 06, 2026
This digest highlights cannabis cognitive aging research alongside promising cannabinoid liver disease studies. It also addresses ongoing drug testing challenges. These insights reflect the evolving landscape of cannabis medicine.
Daily Digest: Last 48 Hours: Cognitive Safety, End-of-Life Access, and the Impairment Testing Problem — March 06, 2026
This daily digest highlights the impairment testing problem cannabis presents in clinical and policy contexts. It also covers cognitive safety and end-of-life access issues. The focus on impairment testing problem cannabis is crucial for advancing…